Combination Therapy In Dyslipidemia
Latest Publications

TOTAL DOCUMENTS

17

(FIVE YEARS 0)

H-INDEX

2

(FIVE YEARS 0)

Published By Springer International Publishing

9783319204321, 9783319204338

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Lipid-Lowering Therapy and Apheresis: Indications and Outcomes

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_12 ◽

2015 ◽

pp. 143-152

Author(s):

Patrick M. Moriarty ◽

Audrey E. McCalley

Keyword(s):

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy

Download Full-text

Use of Combination Statin and Bile Acid Sequestrant Therapy to Treat Dyslipidemia

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_1 ◽

2015 ◽

pp. 1-10 ◽

Cited By ~ 2

Author(s):

Peter P. Toth ◽

Dragana Nikolic ◽

Manfredi Rizz ◽

Jacek Rysz ◽

Maciej Banach

Keyword(s):

Bile Acid ◽

Bile Acid Sequestrant

Download Full-text

Statins and Lomitapide: A Suitable Response for Homozygous Familial Hypercholesterolemia?

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_8 ◽

2015 ◽

pp. 87-97 ◽

Cited By ~ 1

Author(s):

Angela Pirillo ◽

Alberico Luigi Catapano

Keyword(s):

Familial Hypercholesterolemia ◽

Homozygous Familial Hypercholesterolemia

Download Full-text

The Role of Omega-3 Fatty Acids in Dyslipidemias

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_5 ◽

2015 ◽

pp. 45-64 ◽

Cited By ~ 1

Author(s):

Eric J. Brandt ◽

Michael H. Davidson

Keyword(s):

Fatty Acids ◽

Omega 3 Fatty Acids ◽

Omega 3

Download Full-text

Statins and Mipomersen: Mechanisms of Action and Patient Tolerability

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_7 ◽

2015 ◽

pp. 73-86 ◽

Cited By ~ 1

Author(s):

Jing Pang ◽

Dick C. Chan ◽

Gerald F. Watts

Keyword(s):

Mechanisms Of Action

Download Full-text

Drug Evaluation: Olmesartan Medoxomil + Rosuvastatin for the Treatment of Dyslipidemia and Concomitant Risk Factors: A Chance for Better Compliance?

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_16 ◽

2015 ◽

pp. 191-200 ◽

Cited By ~ 1

Author(s):

Joanna Gozdzikiewicz-Lapinska ◽

Jolanta Malyszko

Keyword(s):

Risk Factors ◽

Drug Evaluation ◽

Olmesartan Medoxomil

Download Full-text

Statins and Ezetimibe

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_3 ◽

2015 ◽

pp. 25-36 ◽

Cited By ~ 1

Author(s):

Ulrich Laufs

Download Full-text

The Cardiovascular Polypill in the Prevention of Cardiovascular Disease

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_14 ◽

2015 ◽

pp. 165-177 ◽

Cited By ~ 1

Author(s):

Melvin Lafeber

Keyword(s):

Cardiovascular Disease ◽

Prevention Of Cardiovascular Disease

Download Full-text

Statins and Fibrates: Should They Be Recommended?

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_2 ◽

2015 ◽

pp. 11-23 ◽

Cited By ~ 1

Author(s):

Piotr Chruściel ◽

Dimitri P. Mikhailidis ◽

Peter P. Toth ◽

Jacek Rysz ◽

Maciej Banach

Download Full-text

Conclusions and Take Home Message

Combination Therapy In Dyslipidemia ◽

10.1007/978-3-319-20433-8_17 ◽

2015 ◽

pp. 201-205

Author(s):

Maciej Banach

Download Full-text